Overexpression of the ERK/MAP kinases in oral squamous cell carcinoma

Modern Pathology

Volumn 11, Issue 9, 1998, Pages 886-891

  Mishima, Kenji ^a,b   Yamada, Eiji ^a   Masui, Katsuya ^a   Shimokawara, Tatsuo ^a   Takayama, Kenichi ^a   Sugimura, Masahito ^a   Ichijima, Kunio ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

In situ hybridization; Ki 67; MAPK; Oral squamous cell carcinoma; Overexpression

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; BIOPSY TECHNIQUE; CELL PROLIFERATION; CLINICAL ARTICLE; GENE OVEREXPRESSION; GINGIVA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ANTIGENS, NUCLEAR; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; KI-67 ANTIGEN; MOUTH MUCOSA; MOUTH NEOPLASMS; NUCLEAR PROTEINS; RNA, MESSENGER;

EID: 0031656674     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Lenormand P, Sardet C, Pages G, L'Allemain G, Brunet A, Pouyssegur J. Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase (p45mapkk) in fibroblasts. J Cell Biol 1993; 122:1079-88.
2. Han J, Lee JD, Bibbs L, Ulevivitch RJ. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994;265:808-11.
3. Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD, et al. ERKs: a family of protein-serine/ threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 1991;65:663-75.
4. Landreth GE, Smith DS, McCabe C, Gittinger C. Characterization of a nerve growth factor-stimulated protein kinase in PC12 cells which phosphorylates microtubule-associated protein 2 and pp250. J Neurochem 1990;55:514-23.
5. Gomez N, Cohen P. Dissection of the protein kinase cascade by which nerve growth factor activates MAP kinases. Nature 1991;353:170-3.
6. Gille H, Kortenjann M, Thomae O, Moomaw C, Slaughter C, Cobb MH, et al. ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO J 1995;14:951-62.
7. Baba M, Yamamoto R, Iishi H, Tatsuta M. Ha-ras mutations in N-nitrosomorpholine-induced lesions and inhibition of hepatocarcinogenesis by antisense sequences in rat liver. Int J Cancer 1997;72:815-20.
8. Satoh M, Hatakeyama S, Sashima M, Suzuki A. Immunohistochemical detection of ras 21 in oral squamous cell carcinomas. Oral Surg Oral Med Oral Pathol 1992;74:469-72.
9. Holst VA, Finkelstein S, Colby TV, Myers JL, Yousem SA. p53 and K-ras mutational genotyping in pulmonary carcinosarcoma, spindle cell carcinoma, and pulmonary blastoma: implications for histogenesis. Am J Surg Pathol 1997;21:801-11.
10. Kuo MY, Chang HH, Hahn LJ, Wang JT, Chiang CP. Elevated ras p21 expression in oral premalignant lesions and squamous cell carcinoma in Taiwan. J Oral Pathol Med 1995;24:255-60.
11. Sakata K. Alterations of tumor suppressor genes and the H-ras oncogene in oral squamous cell carcinoma. J Oral Pathol Med 1996;25:302-7.
12. Schmitz-Drager BJ, Schulz WA, Jurgens B, Gerharz CD, van Roeyen CR, Bultel H, et al. c-myc in bladder cancer: clinical findings and analysis of mechanism. Urol Res 1997; 25(Suppl):S45-S49.
13. Rochlitz CF, Herrmann R, de Kant E. Overexpression and amplification of c-myc during progression of human colorectal cancer Oncology 1996;53:448-54.
14. Jones GJ, Heiss NS, Veale RB, Thornley AL. Amplification and expression of the TGF-α, EGF receptor, and c-myc genes in four human oesophageal squamous cell carcinoma lines. Biosci Rep 1993;13:303-12.
15. Jung M, Notario V, Dritschilo A. Mutations in the p53 gene in radiation-sensitive and -resistant human squamous carcinoma cells. Cancer Res 1992;52:6390-3.
16. Loda M, Capodieci P, Mishra R, Yao H, Corless C, Grigioni W, et al. Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis. Am J Pathol 1996;149:1553-64.
17. Schmidt CM, McKillop IH, Cahill PA, Sitzmann JV. Increased MAPK expression and activity in primary human hepatocellular carcinoma. Biochem Biophys Res Commun 1997;236:54-8.
18. Mii S, Khalil RA, Morgan KG, Ware JA, Kent KC. Mitogen-activated protein kinase and proliferation of human vascular smooth muscle cells. Am J Physiol 1996;270(1 Pt. 2):H142-H150.
19. Lin LL, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ. cPLA2 is phosphorylated and activated by MAP kinase. Cell 1993;72:269-78.
20. Xing J, Ginty DD, Greenberg ME. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 1996;273:959-63.
21. Meloche S. Cell cycle re-entry of mammalian fibroblasts is accompanied by the sustained activation of p44mapk and p42mapk isoforms in the G1 phase and their inactivation at the G1/S transition. J Cell Physiol 1995;163:577-88.
22. Le PR, Coulomb B, Miteva L, Houdebine LM. Epidermal growth factor stimulates mitogen-activated protein kinase by a PKC-dependent pathway in human keratinocytes. Biochem Biophys Res Commun 1995;208:245-52.
23. Lu SH, Hsieh LL, Luo FC, Weinstein IB. Amplification of the EGF receptor and c-myc genes in human esophageal cancers. Int J Cancer 1988;42:502-5.
24. Partridge M, Gullick WJ, Langdon JD, Sherriff M. Expression of epidermal growth factor receptor on oral squamous cell carcinoma. Br J Oral Maxillofac Surg 1988;26:381-9.
25. Kusukawa J, Harada H, Shima I, Sasaguri Y, Kameyama T, Morimatsu MS. The significance of epidermal growth factor receptor and matrix metalloproteinase-3 in squamous cell carcinoma of the oral cavity. Eur J Cancer B Oral Oncol 1996;32:217-21.
26. Amundadottir LT, Leder P. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes. Oncogene 1998;16:737-46.
27. Atten MJ, Attar BM, Holian O. Decreased MAP kinase activity in human gastric adenocarcinoma. Biochem Biophys Res Commun 1995;212:1001-6.
28. Attar BM, Atten MJ, Holian O. MAPK activity is down-regulated in human colon adenocarcinoma: correlation with PKC activity. Anticancer Res 1996;16:395-9.